(Q43187366)

15 November 2017

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Causes of death need confirmation (English)

1 reference

15 November 2017

1 reference

1

Jellinger KA

1 reference

15 November 2017

PMC publication ID

2350538

language of work or name

English

0 references

publication date

1 March 1996

1 reference

15 November 2017

1 reference

15 November 2017

312

1 reference

15 November 2017

7032

1 reference

15 November 2017

704-705

1 reference

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

15 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350538

Reliability of death certificate diagnoses

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350538

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350538

Mortality in patients with Parkinson's disease

25 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8597751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.312.7032.704

1 reference

15 November 2017

1 reference

PMC publication ID

2350538

15 November 2017

PubMed publication ID

8597751

1 reference

PMC publication ID

2350538